Protect, Challenge, Launch: Recent IP Updates from Europe, Asia and Australia
Agenda
- Recent developments in PTEs, change in position on disclosure of best method; position of the court on PIs.
- RPD/patent linkage and updates on PRC patent litigation.
- UPC by the numbers, annual update of UPC developments in pharma case law (Court of Appeal’s inventive step approach, the infringement test in second medical use claims, “imminent infringement” and scope and threshold for orders to preserve evidence in biosimilar disputes).
- Updates on plausibility and SPC case law; PIs and general market access trends.
Our Speakers
Jane Owen - Australia
Senior Consultant, Sydney
Jane Owen is a former partner and now Senior Consultant in Sydney. She advises clients on complex IP strategy and disputes, with a focus on life sciences and higher education.
Her experience includes patent litigation, IP portfolio strategy, commercialisation and enforcement.
Alison Wong – China
Partner, Hong Kong, Head of the Life Sciences & Healthcare Sector Group in Asia
Alison Wong advises clients in the life sciences, healthcare, food and beverage, and retail and consumer sectors.
Her practice includes advising pharmaceutical, biotechnology and medical device companies on regulatory matters, market authorisations, clinical trial agreements, public procurement, R&D agreements and technology licensing.
Edoardo Barbera – UPC
Partner, Intellectual Property Group, Milan
Edoardo Barbera specialises in intellectual property protection and enforcement, including patent litigation before national courts and the Unified Patent Court.
His practice covers electronics, telecommunications and life sciences, including medical devices and pharmaceuticals.
Krishna Kakkaiyadi – UK
Krishna Kakkaiyadi is a patent litigator and solicitor advocate with a background in life sciences.
He advises clients ranging from biotechnology companies and start-ups to international pharmaceutical companies on patent disputes, litigation strategy and related regulatory and transactional matters.